Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients... von Hoffknecht, Petra, Tufman, Amanda, Wehler, Thomas, Pelzer, Theo, Wiewrodt, Rainer, Schütz, Martin, Serke, Monika, Stöhlmacher-Williams, Jan, Märten, Angela, Maria Huber, Rudolf, Dickgreber, Nicolas J.

Volltext

A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non‐small cell lu... von Wehler, Thomas, Thomas, Michael, Schumann, Christian, Bosch-Barrera, Joaquim, Viñolas Segarra, Nuria, Dickgreber, Nicolas J, Dalhoff, Klaus, Sebastian, Martin, Corral Jaime, Jesus, Alonso, Miriam, Hynes, Scott M, Lin, Ji, Hurt, Karla, Bence Lin, Aimee, Calvo, Emiliano, Paz-Ares, Luis

Volltext

Phase I and Pharmacokinetic Study of Pemetrexed plus Cisplatin in Chemonaive Patients with Locally Advanced or Metastatic Malignant Pleural Mesothelioma or Non–Small Cell Lung Canc... von Dickgreber, Nicolas J, Fink, Thomas H, Latz, Jane E, Hossain, Anwar M, Musib, Luna C, Thomas, Michael

Volltext

Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid von DICKGREBER, Nicolas J, BENN SORENSEN, Jens, PAZ-ARES, Luis G, KJESTRUP SCHYTTE, Tine, LATZ, Jane E, SCHNECK, Karen B, ZHENG YUAN, SANCHEZ-TORRES, José Miguel

Volltext

Image-Guided Hypofractionated Small Volume Radiotherapy of Non-Small Cell Lung Cancer – Feasibility and Clinical Outcome von Janssen, Stefan, Dickgreber, Nicolas J., Koenig, Carolin, Bremer, Michael, Werner, Martin, Karstens, Johann H., Welte, Tobias, Meyer, Andreas

Volltext

NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy von Trummer, Arne Rainer, Bethge, Andre, Dickgreber, Nicolas J., Dittrich, Ina, Golpon, Heiko, Hoffknecht, Petra, Overbeck, Tobias R., Wesseler, Claas, Reck, Martin

Volltext

Safety and resource use in the PROCLAIM study comparing 2 regimens of concurrent chemoradiation followed by consolidation chemotherapy in locally advanced nonsquamous non-small cel... von Govindan, Ramaswamy, Senan, Suresh, Dickgreber, Nicolas J., Provencio, Mariano, Wu, Yi-Long, Syrigos, Konstantinos N., Parente, Bárbara, Chouaki, Nadia, Hossain, Anwar, San Antonio, Belén, Winfree, Katherine B., Vokes, Everett E.

Volltext

Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive ( EGFRm +) non-small cell lung cancer (NSCLC) von Yang, James Chih-Hsin, Ahn, Myung-Ju, Dickgreber, Nicolas J., Halmos, Balazs, Hirsh, Vera, Hochmair, Maximilian J., Levy, Benjamin Philip, De Marinis, Filippo, Mok, Tony, O'Byrne, Kenneth, Okamoto, Isamu, Schuler, Martin H., Sebastian, Martin, Shah, Riyaz N.H., Tan, Eng-Huat, Yamamoto, Nobuyuki, Marten, Angela, Massey, Dan, Wind, Sven, Carbone, David Paul

Volltext

Lungenkrebs behandeln und begleiten - auf dem Weg zur chronischen Krankheit von Schumann, Christian, Dickgreber, Nicolas J.

Volltext

Lungenkrebs behandeln und begleiten - auf dem Weg zur chronischen Krankheit von Schumann, Christian, Dickgreber, Nicolas J.

Volltext

4 Paclitaxel as 2nd-line monochemotherapy — a reasonable approach von Dickgreber, Nicolas J., Klante, Thomas, Lindemann, Diane, Golpon, Heiko A., Buschmann, Hans C., Welte, Tobias

Volltext

Preclinical analyses and phase I evaluation of LY2603618 administered in combination with Pemetrexed and cisplatin in patients with advanced cancer von Calvo, Emiliano, Chen, Victor J., Marshall, Mark, Ohnmacht, Ute, Hynes, Scott M., Kumm, Elizabeth, Diaz, H. Bruce, Barnard, Darlene, Merzoug, Farhana F., Huber, Lysiane, Kays, Lisa, Iversen, Philip, Calles, Antonio, Voss, Beatrice, Lin, Aimee Bence, Dickgreber, Nicolas, Wehler, Thomas, Sebastian, Martin

Volltext